Repurposed cancer drug shows promise for Parkinson’s

News

Author: Simge Eva DoganPublished: 5 December 2018

Prep: Cook: Serves:

Researchers at the Oxford Parkinson’s Disease Centre, UK, have repurposed an experimental cancer drug – called tasquinimod – as a potential treatment for Parkinson’s.

The study – funded by Parkinson’s UK and published in science journal ‘Cell Stem Cell’ – has been tested on a total of 10 patients so far.

As part of the research, the study grew brain cells from donated skin cell samples of people living with a rare genetic form of Parkinson’s – this process was then repeated on people with a common non-genetic form of the condition. Researchers found that tasquinimod can block HDAC4, a protein that causes Parkinson’s genes to become inactive.

Professor Richard Wade-Martins, co-lead author of the study, said: “We think that switching off these genes in brain cells may play a vital role in the cell damage and death that occurs in Parkinson’s.”

To read more on this topic click here.

For more information on the latest Parkinson’s research please visit the EPDA website.

World’s largest Parkinson’s study seeks 10,000 participants

Last Month

Next Month

Go Back

Share this story

Comments

Europe

My dad’s diagnosis inspired me to become an Ironman

Ironman athlete inspired by father's response to Parkinson's

“It is time for us to act more aggressively to end Parkinson’s”

Four Parkinson’s experts share their plan to end Parkinson’s

Tonya’s trends: ‘off the shoulder’ – a low-slung look on the up

This season’s off the shoulder trend hides DBS surgery scars

Why is it harder to cross obstacles when you have Parkinson’s disease?

A team of researchers at São Paulo State University, Brazil, have offered insights on why people with Parkinson’s disease can find it more difficult to cross obstacles than those without the condition. As part of the study, 13 people with Parkinson’s disease and 11 controls stepped over an obstacle 15 times, and scientists measured the distance between the foot and the obstacles during the step. They found that step-length synergy – the ability of the musculoskeletal system to adapt movement when encountering an obstacle – was 53% lower in people with the condition. “There are patients in our exercise group who fall three or four times a week,” said Fabio Augusto Barbieri, one of the study authors. “It’s important to understand how these patients’ gait and locomotion adapt while crossing obstacles so that we can improve step-length synergy.”

Take part in The Parkinson Tulip Project

This April, The World Parkinson Coalition is launching The Parkinson Tulip Project – a global collaborative photography campaign to raise awareness of the world’s fastest growing neurological disease. As part of the campaign, which is supported by Supernus Pharmaceuticals, members of the Parkinson’s community are invited to share a photo of themselves with tulips – the official symbol of Parkinson’s disease. The project will run until April 2022, and all images shared by the community will be displayed at the sixth World Parkinson Congress in Barcelona, Spain. Additionally, every photo submitted will be entered into The Parkinson Tulip Project raffle. The World Parkinson Coalition hopes that the project will “give a face and name to those impacted by Parkinson’s” and “inspire the community, reminding people touched by Parkinson’s disease that they are not alone”.

Looking after dental health with Parkinson’s disease

Parkinson’s disease symptoms and medications can cause dental health problems – including difficulty cleaning teeth and increased tooth decay. Now, a study from researchers in Brazil has offered dental care recommendations to help people living with the condition. Analysing data from 14 studies, the scientists highlighted people with Parkinson’s can have “reduced quality of oral health and hygiene”. Their advice included routine teeth-brushing, as well as regular trips to a dentist. They also suggested brushing teeth with both hands, as symptoms like tremor and rigidity could mean using one hand is more difficult. The researchers wrote: “Although oral diseases are largely preventable, they are among the most prevalent diseases globally, thus creating a public health problem. “Despite the relatively low level of evidence in studies on oral health among patients with Parkinson’s disease, the data retrieved for this systematic review allowed us to create a set of simple guidelines.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Phone
This field is for validation purposes and should be left unchanged.

Repurposed cancer drug shows promise for Parkinson’s

News

Author: Simge Eva DoganPublished: 5 December 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Europe

My dad’s diagnosis inspired me to become an Ironman

Interviews

“It is time for us to act more aggressively to end Parkinson’s”

Perspectives

Tonya’s trends: ‘off the shoulder’ – a low-slung look on the up

Why is it harder to cross obstacles when you have Parkinson’s disease?

Take part in The Parkinson Tulip Project

Looking after dental health with Parkinson’s disease

{title}

Subscribe

Repurposed cancer drug shows promise for Parkinson’s

News

Author: Simge Eva DoganPublished: 5 December 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Europe

My dad’s diagnosis inspired me to become an Ironman

Interviews

“It is time for us to act more aggressively to end Parkinson’s”

Perspectives

Tonya’s trends: ‘off the shoulder’ – a low-slung look on the up

Why is it harder to cross obstacles when you have Parkinson’s disease?

Take part in The Parkinson Tulip Project

Looking after dental health with Parkinson’s disease

{title}

Subscribe

Sign in